NCT02431923View on ClinicalTrials.gov

Ebola Virus Disease Survivors: Clinical and Immunologic Follow-up

CompletedOBSERVATIONAL
Enrollment

4,043

Participants

Timeline

Start Date

December 2, 2017

Primary Completion Date

April 30, 2021

Study Completion Date

April 30, 2021

Conditions
Ebola Virus Disease
Trial Locations (4)

20892

National Institutes of Health Clinical Center, Bethesda

Unknown

CH Rennie Hospital, Kakata

Duport Clinic, Monrovia

JFK Hospital, Monrovia

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT02431923 - Ebola Virus Disease Survivors: Clinical and Immunologic Follow-up | Biotech Hunter | Biotech Hunter